Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-17
Closed -$216 2772
2022
Q4
$216 Buy
+17
New +$298 ﹤0.01% 2720
2022
Q2
Sell
-18
Closed -$1K 2461
2022
Q1
$1K Buy
18
+10
+125% +$435 ﹤0.01% 2147
2021
Q4
$0 Sell
8
-1,070
-99% -$66.1K ﹤0.01% 2059
2021
Q3
$67K Sell
1,078
-92
-8% -$6.05K 0.02% 360
2021
Q2
$99K Buy
1,170
+270
+30% +$24.6K 0.02% 297
2021
Q1
$71K Sell
900
-400
-31% -$26K 0.02% 346
2020
Q4
$76K Buy
1,300
+800
+160% +$37.7K 0.02% 293
2020
Q3
$17K Sell
500
-829
-62% -$31.4K ﹤0.01% 658
2020
Q2
$61K Sell
1,329
-1,371
-51% -$38.2K 0.02% 315
2020
Q1
$43K Buy
2,700
+2,200
+440% +$52.4K 0.02% 355
2019
Q4
$14K Sell
500
-500
-50% -$13.4K ﹤0.01% 821
2019
Q3
$29K Hold
1,000
0.01% 582
2019
Q2
$28K Sell
1,000
-300
-23% -$10.1K 0.01% 595
2019
Q1
$54K Buy
1,300
+50
+4% +$1.8K 0.02% 376
2018
Q4
$38K Buy
+1,250
New +$46.5K 0.02% 421

Other funds holding AFMD

Lindbrook Capital's AFMD Position: Q1 2023 in Review

Lindbrook Capital sold out of Affimed (AFMD) in Q1 2023, closing a stake of 17 shares — an estimated $216 sold.

Lindbrook Capital first reported a position in AFMD in Q4 2018 and held it in 15 quarters. The position peaked at $99K in Q2 2021. 94 funds tracked by Wall St. Rank hold AFMD as of Q1 2023.

  • Lindbrook Capital reported no remaining Affimed position as of Q1 2023 after selling out during the quarter.
  • Lindbrook Capital sold 17 Affimed shares in Q1 2023, an estimated $216.
  • Lindbrook Capital first reported a position in Affimed in Q4 2018 and held it in 15 quarters.
  • Lindbrook Capital's Affimed position peaked at $99K in Q2 2021.
  • 94 funds tracked by Wall St. Rank held Affimed as of Q1 2023.

Based on Lindbrook Capital's 13F filing for Q1 2023, filed 26 Apr 2023.